Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation
C-C Tang, G Isitman, J Bruneau, C Tremblay, NF Bernard, SJ Kent, MS Parsons
Clinical & Experimental Immunology | WILEY-BLACKWELL | Published : 2015
Awarded by National Health and Medical Research Council (NHMRC)
Awarded by Canadian Institutes for Health Research (CIHR)
Awarded by Alberta Innovates
We acknowledge Rachel Bouchard and Stephanie Matte for co-ordinating the cohorts of HIV-uninfected and HIV-infected slow progressors utilized for NK cell phenotyping studies. The following physicians are acknowledged for recruiting and following HIV-infected slow progressors: Dr Danielle Rouleau, Dr Colin Kovacs, Dr Mona Loutfy, Dr Marianne Harris, Dr Benoit Trottier, Dr Jean-Pierre Routy, Dr Anita Rachlis, Dr Pierre Cote, Dr Marian Klien, Dr Bertrand Lebouche, Dr Alan Piche, Dr Kenneth Logue and Dr Edward Ralph. Finally, we would like to acknowledge the study participants. This work was supported by programme grant number 510448 from the National Health and Medical Research Council (NHMRC), as well as grants from the Canadian Institutes for Health Research (CIHR) numbers HOP-123800, MOP-111155 and THA-118628 and the Fonds de la Recherche du Quebec Sante (FRQ-S) AIDS and Infectious Diseases Network. G. I. is the recipient of a Canadian HIV Trials Network postdoctoral fellowship. N. F. B. is a member of the Research Institute of the McGill University Health Centre, an institution funded in part by the FRQ-S. M. S. P. is the recipient of a CIHR postdoctoral fellowship.